Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.06% is 20% above its 5-year average of 1.72%, near the high end of its 5-year range (-1.92%–3.35%).
36.22% below its 12-month average of 3.23%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
2.06%
RETURN ON ASSETS (ROA) AVG TTM
3.23%
RETURN ON ASSETS (ROA) AVG 3Y
2.72%
RETURN ON ASSETS (ROA) AVG 5Y
1.72%
RETURN ON ASSETS (ROA) AVG 10Y
0.77%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-36.22%
CURRENT VS 3Y AVG
-24.40%
CURRENT VS 5Y AVG
+19.77%
CURRENT VS 10Y AVG
+167.22%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.18%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-60.23%
vs the sector median at left
Market Cap
$34.53B
Return on Assets (ROA)
16.99%
TTM Avg
17.06%
3Y Avg
15.57%
5Y Avg
14.60%
Market Cap
$34.04B
Return on Assets (ROA)
15.49%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
Market Cap
$32.35B
Return on Assets (ROA)
4.27%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
Market Cap
$32.06B
Return on Assets (ROA)
17.35%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
Market Cap
$31.84B
Return on Assets (ROA)
-6.14%
TTM Avg
-2.29%
3Y Avg
0.04%
5Y Avg
0.75%
Market Cap
$31.34B
Return on Assets (ROA)
14.54%
TTM Avg
-0.12%
3Y Avg
-10.91%
5Y Avg
-15.37%
Market Cap
$30.85B
Return on Assets (ROA)
0.67%
TTM Avg
13.34%
3Y Avg
15.53%
5Y Avg
17.15%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alcon Inc. (ALC) | $34.81B | 2.06% | 3.23% | 2.72% | 1.72% |
| ResMed Inc. (RMD)vs › | $34.53B | 16.99% | 17.06% | 15.57% | 14.60% |
| DexCom, Inc. (DXCM)vs › | $34.04B | 15.49% | 11.04% | 9.26% | 8.83% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $32.35B | 4.27% | 5.83% | 5.87% | 14.86% |
| Biogen Inc. (BIIB)vs › | $32.09B | 2.60% | 5.11% | 6.74% | 8.29% |
| Zoetis Inc. (ZTS)vs › | $32.06B | 17.35% | 17.37% | 16.33% | 15.33% |
| Centene Corp. (CNC)vs › | $31.84B | -6.14% | -2.29% | 0.04% | 0.75% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $31.34B | 14.54% | -0.12% | -10.91% | -15.37% |
| Waters Corporation (WAT)vs › | $30.85B | 0.67% | 13.34% | 15.53% | 17.15% |
| Medline Inc. (MDLN)vs › | $29.76B | 1.76% | 3.17% | 1.75% | 1.75% |
ROA
2.1%
ROE
3.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.11% |
| 2024-12-31 | 3.35% |
| 2023-12-31 | 3.29% |
| 2022-12-31 | 1.15% |
| 2021-12-31 | 1.34% |
| 2020-12-31 | -1.92% |
| 2019-12-31 | -2.37% |
| 2018-12-31 | -0.84% |
| 2017-12-31 | 0.93% |
| 2016-12-31 | -0.61% |
| 2015-12-31 | 1.05% |
